within Pharmacolibrary.Drugs.S_SensoryOrgans.S02D_OtherOtologicals.S02DA30_PolymyxinBAndNeomycinCombination;

model PolymyxinBAndNeomycinCombination
  extends Pharmacolibrary.Drugs.ATC.S.S02DA30;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S02DA30</td></tr><td>route:</td><td>otic</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>A combination of polymyxin B and neomycin (ATC code S02DA30), used as an otic (ear) solution for the treatment of bacterial infections of the external ear. Such combinations typically include hydrocortisone or other anti-inflammatory agents. While once widely used, some of these combinations have become less common in modern therapy, but are still available in some regions and formulations.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data found specifically for the combination product polymyxin B and neomycin administered otically in healthy adults or children. Pharmacokinetic parameters estimated based on data available for individual drugs administered via systemic or topical routes; minimal systemic absorption expected with otic administration unless tympanic membrane is perforated.</p><h4>References</h4><ol><li><p>Hebert, RL, et al., &amp; Bent, JP (2000). Tympanostomy tubes and otic suspensions: do they reach the middle ear space?. <i>Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery</i> 122(3) 330–333. DOI:<a href=&quot;https://doi.org/10.1016/S0194-5998(00)70042-8&quot;>10.1016/S0194-5998(00)70042-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10699804/&quot;>https://pubmed.ncbi.nlm.nih.gov/10699804</a></p></li><li><p>Ikeda, K, &amp; Morizono, T (1990). Round window membrane permeability during experimental purulent otitis media: altered Cortisporin ototoxicity. <i>The Annals of otology, rhinology &amp; laryngology. Supplement</i> 148 46–48. DOI:<a href=&quot;https://doi.org/10.1177/00034894900990s613&quot;>10.1177/00034894900990s613</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2161637/&quot;>https://pubmed.ncbi.nlm.nih.gov/2161637</a></p></li><li><p>Hotmes, WF, et al., &amp; Alford, E (1989). Generic vs. proprietary otic drops. <i>Transactions - Pennsylvania Academy of Ophthalmology and Otolaryngology</i> 41 859–860. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2561028/&quot;>https://pubmed.ncbi.nlm.nih.gov/2561028</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end PolymyxinBAndNeomycinCombination;
